 |
Australia's pharmaceutical cost sharing policy: reducing waste or affordability? |
Doran, Evan; Robertson, Jane |
2009 |
—
|
|
 |
Australian pharmaceutical policy and the idea of innovation |
Doran, Evan; Henry, David; Faunce, Thomas A.; Searles, Andrew |
2008 |
|
|
 |
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia |
Doran, Evan; Henry, David; Fauce, Thomas A.; Searles, Andrew |
2008 |
—
|
|
 |
Disease mongering is now part of the global health debate |
Moynihan, Ray; Doran, Evan; Henry, David |
2008 |
|
|
 |
Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme |
Searles, Andrew; Jefferys, Susannah; Doran, Evan; Henry, David A. |
2007 |
—
|
|
 |
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience |
Henry, David Alexander; Kerridge, I. H.; Hill, Suzanne; McNeill, P. M.; Doran, Evan... More
|
2005 |
—
|
|
 |
Moral hazard and prescription medicine use in Australia - the patient perspective |
Doran, Evan; Robertson, Jane; Henry, David |
2005 |
—
|
|
 |
Moral hazard and prescription medicine use in Australia: the patient perspective |
Doran, Evan; Robertson, Jane; Henry, David |
2005 |
—
|
|
 |
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry |
Henry, David; Doran, Evan; Kerridge, Ian; Hill, Suzanne; McNeill, Paul M.... More
|
2005 |
—
|
|
List View
